How do you take sodium bicarbonate?

Forms and strengths
ProductForm and strength
Rugby antacid5 gr (325 mg) tablet1
Graxcell10 gr (650 mg) tablet3 or 5 gr (325 mg) tablet4
Arm and Hammer baking sodaPowder, sodium bicarbonate 100%5

The Rugby antacid label gives 2-8 tablets every 4 hours for adults under 60 and 2-4 tablets for adults 60 and over, and the ISSN position stand says a single dose of 0.3 g/kg seems to be optimal, 60 to 180 minutes before exercise.12

Forms and strengths

The table is set at the top of the page

How tablets and powder are mixed

The Rugby label says tablets may be swallowed whole or dissolved in water.1 The Graxcell label directs one tablet dissolved in a glass of water, dissolved completely before drinking.3 The Arm and Hammer label gives the powder as a half teaspoon in 4 fl. oz. of water.5 The labels count their doses in tablets or half teaspoons, and none gives a mL volume or syringe mark for oral use. In a crossover study of twelve trained healthy males, 300 mg kg−1 body mass was given either as a solution made with 400 mL of mineral water and 50 mL of squash, or in delayed-release capsules.6

What the labels give for dose and duration

LabelDoseDaily maximum
Rugby 325 mg tablets12 to 4 tablets every 4 hours (60 and over); 2 to 8 tablets every 4 hours (under 60)24 tablets (60 and over); 48 tablets (under 60)
Graxcell 650 mg tablets3Adults: 1 tablet, dissolved in a glass of water, as needed24 tablets (adults up to 60); 12 tablets (60 and over)
Arm and Hammer powder51/2 teaspoon in 4 fl. oz. of water every 2 hoursSeven half teaspoons; three if over 60

The Rugby label limits use of the maximum dosage to 2 weeks and says to stop and ask a doctor if symptoms last longer.1 For the same 325 mg strength, the Graxcell 5 gr label gives a lower maximum than the Rugby label: 24 tablets for adults up to 60 and 12 for adults 60 and over.41 The Arm and Hammer label says not to give the antacid to children under age 5, and lists 656 mg of sodium per half teaspoon.5 The Rugby label lists 89 mg of sodium per tablet and says to ask a doctor before use on a sodium restricted diet, while the Graxcell labels list 178 mg (7.74 meg) of sodium per tablet in both strengths.134

What the sports position stand says

For a single dose, the ISSN position stand says 0.2 g/kg seems to be the minimum dose for improvements in exercise performance and 0.3 g/kg seems to be optimal, taken 60 to 180 minutes before exercise or competition.2 For multiple-day protocols, it says these generally last 3 to 7 days before the exercise test at a total of 0.4 or 0.5 g/kg per day, divided into smaller doses, for example 0.1 to 0.2 g/kg at breakfast, lunch and dinner.2 It says single doses of 0.4 or 0.5 g/kg may not be required, as they add no benefit over 0.3 g/kg and bring more side-effects, and lists smaller doses, timing near 180 minutes before exercise, a high-carbohydrate meal and enteric-coated capsules as possible ways to lessen them.2

What the trials gave in sports and kidney disease

TrialDose and schedulePeopleLength
Hilton, cyclists70.3 g∙kg–1 body mass in enteric-coated or gelatin capsules, or placeboEleven trained male cyclistsThree 4 km time trials
Hilton 2020, capsules8300 mg/kg body mass in gelatin, delayed-release or enteric-coated capsules, or placebo14 trained malesBlood and symptoms measured for 3 hr after ingestion
BASE pilot (Raphael, 2020)90.8 or 0.5 meq/kg lean body weight, or placebo194 adults with chronic kidney disease (90, 52, 52)28 weeks, then 4 weeks off
Preserve-Transplant (Mohebbi, 2023)101·5-4·5 g per day in acid-resistant 500 mg capsules, three times daily, or placebo242 adult kidney transplant recipients with metabolic acidosis (120, 122)2 years

The record of the Alkali Therapy in Chronic Kidney Disease trial gives 0.4 mEq/kg/day of ideal body weight once a day, with 149 enrolled and a 2 year time frame.11 In the BASE pilot trial, doses of 0.8 and 0.5 meq/kg per day were both well tolerated over 28 weeks, and mean ACR rose by 30% with the higher dose against 12% with the lower dose.9

Storage

The Rugby tablet label gives storage in a dry place at 15º - 30ºC, and the Graxcell tablet labels give room temperature, 15°-30°C, in well-closed containers.134 The Arm and Hammer label says to discard its skin compress mixture after each use, and gives no storage period for a drinking solution.5 No label saved gives a storage time or temperature for a mixed oral solution; in the crossover study of twelve trained healthy males, the solution was refrigerated for about 1 h.6

Frequently asked questions

Is there a cycle for sodium bicarbonate?

No cycle is stated for sodium bicarbonate in any label or trial saved.

Is there a label for pool or cleaning use?

No label, regulator page or human trial for pool, cleaning or water-treatment use was saved.

What do Milligram users log?

Milligram's logs hold no sodium bicarbonate figure to report.

References

  1. DailyMed. 4621 - Rugby. 2026. dailymed.nlm.nih.gov
  2. PMC. International Society of Sports Nutrition position stand: sodium bicarbonate and exercise performance. 2021. pmc.ncbi.nlm.nih.gov
  3. DailyMed. Sodium Bicarbonate 10 gr (650 mg), 70795-1190. 2026. dailymed.nlm.nih.gov
  4. DailyMed. Sodium Bicarbonate 5 gr (325 MG), 70795-1180. 2026. dailymed.nlm.nih.gov
  5. DailyMed. Arm and Hammer Baking Soda. 2026. dailymed.nlm.nih.gov
  6. PMC. A Novel Ingestion Strategy for Sodium Bicarbonate Supplementation in a Delayed-Release Form: a Randomised Crossover Study in Trained Males. 2019. pmc.ncbi.nlm.nih.gov
  7. PMC. Enteric-coated sodium bicarbonate supplementation improves high-intensity cycling performance in trained cyclists. 2020. pmc.ncbi.nlm.nih.gov
  8. PubMed. Enteric-Coated Sodium Bicarbonate Attenuates Gastrointestinal Side-Effects. 2020. pubmed.ncbi.nlm.nih.gov
  9. PMC. A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial. 2020. pmc.ncbi.nlm.nih.gov
  10. PubMed. Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial. 2023. pubmed.ncbi.nlm.nih.gov
  11. ClinicalTrials.gov. NCT01452412: Alkali Therapy in Chronic Kidney Disease. 2011. clinicaltrials.gov